Daratumumab for the Treatment of Multiple Myeloma

This mini-review will summarize the present state of development of the CD38 antibody daratumumab for the treatment of multiple myeloma.

Bibliographic Details
Main Authors: Torben Plesner, Jakub Krejcik
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-06-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2018.01228/full